T20K

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameT20K
Drug Alias NameT-20K
ClassificationSmall molecules > Synthetic peptideNatural product/Extract
Mechanisms of ActionInterleukin-2 inhibitors
TargetsInterleukin-2
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCyxone
China Registration ClassN/A

Develop Information

Active CompaniesCyxone
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A